IntrinsicIntrinsic
← All summaries

XANADU QUANTUM TECHNOLOGIES FORMER SPAC INC.

CHACR
Financials & Chart →

Business Summary

Crane Harbor Acquisition Corp. (the "Company") operates as a blank check company, specifically a Special Purpose Acquisition Company (SPAC), incorporated in the Cayman Islands on January 2, 2025 . Its core business model is to identify and effectuate a business combination, such as a merger, share exchange, or asset acquisition, with one or more operating businesses . The Company has not generated any operating revenues to date and does not expect to do so until the consummation of its initial business combination . Revenue generation is currently limited to non-operating interest income from funds held in a Trust Account . The primary customer segments are not applicable as the Company is pre-business combination. The Company aims to accelerate the growth of target companies by providing operational and strategic expertise, access to new capital, and a pathway to public markets .

The Company intends to pursue initial business combination targets in any industry or geographical location, but specifically believes the technology, real assets, and energy sectors offer compelling opportunities . The focus is on high-growth companies implementing transformative technologies within global connectivity, sustainability, and infrastructure development . The Company leverages an extensive sourcing network including business founders, global funds, private equity, and industry professionals to access attractive investment opportunities .

For the period from January 2, 2025 (inception) through December 31, 2025, the Company reported a net income of $3,584,813 . This was primarily driven by interest earned on cash and investments held in the Trust Account, amounting to $6,096,758 , offset by formation, general, and administrative costs of $2,511,945 . Basic and diluted net income per share for Class A ordinary shares was $0.16 , and for Class B ordinary shares was also $0.16 . As of December 31, 2025, the Company held cash and investments in the Trust Account totaling $226,096,758 , including approximately $6,096,758 of interest earnings . Total current assets were $404,372 , with cash of $267,719 and prepaid expenses of $136,653 . Total liabilities amounted to $10,314,510 , comprising current liabilities of $1,514,510 (including accrued expenses of $739,510 , accrued offering costs of $75,000 , and an advance from a related party of $700,000 ) and a deferred underwriting fee of $8,800,000 . The Company reported a total shareholders' deficit of $(9,873,719) .

During the reported period, the Company consummated its initial public offering on April 28, 2025, selling 22,000,000 units at $10.00 per unit, generating gross proceeds of $220,000,000 . Simultaneously, 640,000 placement units were sold in a private placement at $10.00 per unit, generating total gross proceeds of $6,400,000 . Following these transactions, $220,000,000 was placed in a trust account. The Company incurred $13,786,773 in IPO-related costs, including $4,400,000 in cash underwriting fees and $8,800,000 in deferred underwriting fees. A significant operational development was the entry into a business combination agreement on November 3, 2025, with Xanadu Quantum Technologies Inc. and Xanadu Quantum Technologies Limited ("PubCo") . If consummated, this transaction will result in the Company and Target becoming wholly-owned subsidiaries of PubCo, with PubCo's securities listed on Nasdaq .

Business Outlook

The Company's primary objective for the upcoming period is the consummation of its initial business combination with Xanadu Quantum Technologies Inc. and Xanadu Quantum Technologies Limited, as per the Business Combination Agreement entered into on November 3, 2025 . The Company has a completion window until April 28, 2027, to finalize a business combination . No formal revenue, margin, or EPS guidance for the upcoming period has been issued, as the Company does not expect to generate operating revenues until after the completion of its business combination .

A major growth area for the Company is the acquisition and integration of high-growth companies, particularly those leading in technology, real assets, and energy sectors, which are implementing transformative technologies in global connectivity, sustainability, and infrastructure development . The Company aims to accelerate the growth of these target companies by providing strategic guidance, capital infusion, and access to public markets . The specific target, Xanadu Quantum Technologies Inc., operates in the quantum technologies sector, indicating a focus on advanced technological solutions .

Operationally, the Company expects to continue incurring significant costs in the pursuit of its acquisition plans . The management team's expertise spans strategic planning, financial planning, commercialization, capital markets navigation, and public company operations, which are intended to enhance the value of a target company . The Company's current office space is considered adequate for its operations, and it does not intend to have full-time employees prior to the completion of its initial business combination .

Regarding capital allocation, the Company intends to use substantially all of the funds held in the Trust Account, including interest earned (less income taxes payable), to complete its Business Combination . As of December 31, 2025, $267,719 was available outside the Trust Account for working capital, primarily for identifying and evaluating target businesses, performing due diligence, and structuring transactions . The Sponsor or affiliates may loan up to $2,500,000 for working capital deficiencies or transaction costs, which may be convertible into placement units at $10.00 per unit . The Company has an agreement to pay an affiliate of its sponsor $20,000 per month for office space, utilities, and administrative support until the earlier of business combination completion or liquidation . A deferred underwriting discount of $8,800,000 is payable upon the closing of the initial Business Combination .

Risk Factors

The Company faces several material risks, including the fundamental risk of being a blank check company with no operating history or revenues, meaning there is no basis to evaluate its ability to achieve its business objective . There is a significant risk that the Company may not be able to complete its initial business combination within the completion window of April 28, 2027, which would result in the redemption of public shares and the expiration of Share Rights without value . Public shareholders may not have an opportunity to vote on the proposed business combination, and even if a vote occurs, the initial shareholders and management team, who own 25.9% of the issued and outstanding ordinary shares , have agreed to vote in favor, increasing the likelihood of approval regardless of public shareholder sentiment . The ability of public shareholders to redeem their shares for cash may make the Company's financial condition unattractive to potential targets, potentially hindering the completion of a desirable business combination or optimizing its capital structure, and could substantially dilute non-redeeming shareholders . The nominal purchase price paid by the sponsor for founder shares (approximately $0.003 per share) could result in significant dilution to public shareholders upon business combination consummation, and the sponsor is likely to make a substantial profit even if the trading price of ordinary shares declines . Global geopolitical conditions, such as the Russia-Ukraine conflict and Middle East conflicts, may materially adversely affect the search for a target and the operations or financial condition of potential target companies . The Company's liquidity condition, with only $267,719 cash outside the trust account as of December 31, 2025, raises substantial doubt about its ability to continue as a going concern without additional capital or loans from its sponsor or management . Furthermore, if third parties bring claims against the Company, the proceeds in the trust account could be reduced, potentially leading to a per-share redemption amount less than $10.00 . Changes in laws or regulations, particularly the recently adopted SEC SPAC Rules, may increase costs and time needed to complete a business combination and could lead to the Company being deemed an investment company, imposing burdensome compliance requirements or restricting activities .

Management Priorities

Management's message to shareholders emphasizes their confidence in the team's ability to identify, acquire, and build a company that can benefit from their operational expertise and executive oversight. They highlight their seasoned leadership with a proven track record in operational excellence, capital markets expertise, and successful SPAC transactions, citing examples such as Falcon Minerals, Janus International Group, Vertiv, and BlackSky Technology . The strategic priorities for the period ahead are focused on identifying and pursuing high-growth sectors with favorable market dynamics for long-term value creation, coupled with rigorous due diligence and active post-transaction support to maximize value for shareholders . Management also explicitly states their intention to complete the initial Business Combination before the end of the completion window, which is April 28, 2027 . They acknowledge the need to raise additional capital through loans or investments from the Sponsor, shareholders, officers, directors, or third parties to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, with up to $2,500,000 of such loans potentially convertible into placement units at a price of $10.00 per unit .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Overview
  2. [2] Item 1, Business — Overview
  3. [3] Item 1, Business — Overview
  4. [4] Item 7, MD&A — Results of Operations
  5. [5] Item 1, Business — Overview
  6. [6] Item 1, Business — Overview
  7. [7] Item 1, Business — Overview
  8. [8] Item 1, Business — Overview
  9. [9] Item 7, MD&A — Results of Operations
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Statement of Operations
  13. [13] Item 7, MD&A — Statement of Operations
  14. [14] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  15. [15] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  16. [16] Item 8, Balance Sheet
  17. [17] Item 8, Balance Sheet
  18. [18] Item 8, Balance Sheet
  19. [19] Item 8, Balance Sheet
  20. [20] Item 8, Balance Sheet
  21. [21] Item 8, Balance Sheet
  22. [22] Item 8, Balance Sheet
  23. [23] Item 8, Balance Sheet
  24. [24] Item 8, Balance Sheet
  25. [25] Item 8, Balance Sheet
  26. [26] Item 1, Business — Overview
  27. [27] Item 1, Business — Overview
  28. [28] Item 1, Business — Overview
  29. [29] Item 5, Recent Sales of Unregistered Securities and Use of Proceeds
  30. [30] Item 5, Recent Sales of Unregistered Securities and Use of Proceeds
  31. [31] Item 5, Recent Sales of Unregistered Securities and Use of Proceeds
  32. [32] Item 1, Business — Overview
  33. [33] Item 1, Business — Overview
  34. [34] Item 1, Business — Overview
  35. [35] Item 1, Business — Overview
  36. [36] Item 7, MD&A — Results of Operations
  37. [37] Item 1, Business — Overview
  38. [38] Item 1, Business — Business Strategy
  39. [39] Item 1, Business — Overview
  40. [40] Item 7, MD&A — Overview
  41. [41] Item 1, Business — Business Strategy
  42. [42] Item 1, Business — Employees
  43. [43] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  44. [44] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  45. [45] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  46. [46] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  47. [47] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  48. [48] Item 7, MD&A — Contractual Obligations
  49. [49] Item 7, MD&A — Contractual Obligations
  50. [50] Item 7, MD&A — Contractual Obligations
  51. [51] Item 7, MD&A — Contractual Obligations
  52. [52] Item 1A, Risk Factors — General Risk Factors
  53. [53] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  54. [54] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  55. [55] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  56. [56] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  57. [57] Item 1A, Risk Factors — Risks Relating to our Securities
  58. [58] Item 1A, Risk Factors — Risks Relating to our Securities
  59. [59] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  60. [60] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  61. [61] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  62. [62] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  63. [63] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  64. [64] Item 1, Business — Business Strategy
  65. [65] Item 1, Business — Business Strategy
  66. [66] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  67. [67] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  68. [68] Item 7, MD&A — Liquidity, Capital Resources and Going Concern

Analysis on 5/20/2026